Telehealth Delivered Home-based Walking for Veterans with Peripheral Artery Disease
This study is for Veterans with peripheral artery disease (PAD), a condition where narrowed arteries reduce blood flow to your limbs. It's testing two ways to deliver a home-based walking program: through the internet or through telehealth (video calls with a study coordinator). Both programs include step-count goals, walking tips, and progress tracking for 12 weeks. The goal is to see if these programs can help you walk longer distances and improve your quality of life. You might be eligible if you're a man or woman with PAD, experience leg pain when walking (claudication), can walk at least one city block, and are generally inactive. The study aims to enroll 225 participants.
- Study design
- This study is an interventional, randomized trial involving 225 Veterans. Participants will be assigned to either an internet-based walking program, a telehealth-based walking program, or usual care.
- What's involved
- Participants will engage in a walking program for 12 weeks, either through internet pages or telehealth sessions. Some participants may be re-randomized for a second 12-week period.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome, change in maximal walking distance, will be measured at 12 weeks. Some improvements will also be sustained at 24 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
At a glance
Conditions
Where it's being run
3 sites across 3 statesStudy leadership
- Elizabeth A Jackson, MD · PRINCIPAL_INVESTIGATOR · Birmingham VA Medical Center, Birmingham, AL
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in maximal walking distancebaseline to 12 weeks
measured using the Gardener-Sinner protocol treadmill test, a validated protocol for measuring maximal and claudication free walking distance among patients with PAD, used in clinical care